Objective: To examine the relationship between perceived discrimination and medication adherence among black people with hypertension and the role of stress and depressive symptoms in this relationship. Perceived racial discrimination has been associated with poor health outcomes in blacks; its relationship to medication adherence among hypertensive patients remains untested. Methods: We measured perceived racial discrimination at baseline, stress and depressive symptoms at 6 months, and medication adherence at 12 months among patients enrolled in a 30-site cluster-randomized controlled trial testing a patient and physician-targeted intervention to improve blood pressure. A mediational method with bootstrapping (stratified by site) confidence intervals was used to estimate the indirect association between perceived discrimination and medication adherence through stress and depression. Results: Of 1056 patients from 30 sites enrolled in the trial, 463 had complete data on all four measures at 6 and 12 months and were included in the analyses. Adjusting for clustering, perceived discrimination was associated with poor medication adherence (B = 0.138, p = .011) at 12 months, and with stress (B = 2.24, p = .001) and depression (B = 1.47, p = .001) at 6 months. When stress and depression were included in the model, there was a 65% reduction in the total association of perceived discrimination with medication adherence, and the relationship was no longer significant (B = 0.049, p = .35). Conclusions: Perceived discrimination is associated with poor medication adherence among hypertensive blacks, and stress and depressive symptoms may account for this relationship. Trial Registration: clinicaltrials.gov Identifier: NCT00233220.
INTRODUCTION
M orbidity and mortality due to cardiovascular disease are disproportionately high for black Americans as compared with non-Hispanic whites, and the higher rates of hypertension among blacks account for a large proportion of this disparity (1) . The rate of blood pressure control among people with hypertension remains low, and the rate of control among blacks is significantly lower than that among whites (2, 3) . A variety of factors likely contribute to racial disparities in blood pressure control. One major potentially modifiable factor is poor adherence to antihypertensive medication (4) .
Although antihypertensive medications have been proven effective in controlling blood pressure, adherence rates remain low (5, 6 ). The estimated rates of adherence to antihypertensive medication range from 50% to 70%, depending on a number of factors including the population studied, the class of medication prescribed, study methodology, and measurement of adherence (7) . Research examining sociodemographic correlates of adherence to antihypertensive medication suggests that blacks are significantly less likely than whites to adhere to prescribed medications (4,8Y15). Still, some studies have found equal or better adherence among blacks (16Y18), and at least one found that racial disparities in rates of adherence differed depending on the class of drug prescribed (19) . Developing a better understanding of the various factors that influence the adherence behaviors of black people with hypertension and the mechanisms underlying these factors is essential if the racial disparities in blood pressure control are to be effectively addressed.
Bosworth and Oddone's (20) model of psychosocial and cultural factors influencing blood pressure control provides a useful framework for the examination of medication adherence behaviors among black people with hypertension. They identify three categories of factors that contribute to poor blood pressure control: patient-level characteristics (e.g., demographics, adverse effects, psychosocial variables), the social-cultural environment (e.g., financial barriers, race-related and socioeconomic stressors, mistrust, availability of support networks), and the medical environment (e.g., access to care, provider-patient relationship). Patient characteristics are hypothesized to interact with socialcultural environmental and medical environmental factors to directly and indirectly contribute to blood pressure control by influencing a variety of control behaviors including medication adherence. The conundrum of poor medication adherence among black hypertensive patients likely results from a dynamic interaction of multiple factors, yet most studies have focused primarily on patient characteristics or the medical environment. Thus, we focus here on examining how psychosocial and social-cultural environmental factors might together influence medication-taking behavior among black people with hypertension.
Bosworth and Oddone (20) identify a number of psychosocial factors that may influence medication adherence including motivation, coping style, and depression. A recent review of research on medication adherence among black people with hypertension found that psychosocial factors were consistently associated with adherence in this population (11) . The positive association between depression and poor medication adherence, in particular, is well documented in both crosssectional and longitudinal studies among a variety of populations with chronic diseases including hypertension (21Y27), as well as among black people with hypertension specifically (26, 28) . Another psychosocial factor that may be particularly relevant to black people with hypertension is stress. Because of substantial current and historical racial inequities in housing, employment, income, and education, a disproportionate number of blacks live under conditions of relative socioeconomic deprivation that are associated with greater exposure to chronic stress (29, 30) . Although stress has been examined less frequently in the adherence literature, a number of studies have found positive associations between self-reported acute and chronic stress and poor adherence to antiretroviral medication (16,31Y34) . No studies to date have examined the relationship between stress and adherence to antihypertensive medication, but qualitative studies have found that black hypertensive patients report stress as a significant barrier to medication adherence (8, 35) .
Racial discrimination is a unique source of stress that affects people of color and is an important aspect of the social-cultural environment that has been associated with a variety of poor health outcomes in blacks (36Y38). Two pathways have been proposed to account for the discrimination-health relationship: a) discrimination leads to physiological stress responses, which, when sustained over time, leads to deleterious health outcomes, and b) discrimination leads to the use of negative health behaviors to cope with stress, which ultimately result in poor health outcomes. Most research on discrimination has examined mental health outcomes, finding consistent associations between discrimination (measured via experimental manipulation as well as self-report measures of perceived discrimination) and both subjective indices of stress including distress, anxiety, and depression (36, 37, 39) , as well as objective indices of stress such as cardiovascular reactivity (36Y38, 40, 41) . The association between discrimination and health behaviors such as medication adherence has received limited attention. All but one of the studies conducted to date have found a significant relationship between perceived discrimination and adherencerelated health behaviors including lower adherence to medications among racial/ethnic minority HIV-positive patients (42Y44) and among patients with psychosis (45) , as well as the use of alternative rather than conventional medications to treat serious illness among black and Latino residents of urban public housing developments (46) . Given the consistent associations between discrimination and both psychological and physiological stress responses, and between depression and medication adherence, one mechanism that may explain the relationship between perceived discrimination and medication adherence is that the stress and depression associated with increased perceived exposure to discrimination may reduce patients' ability to maintain consistent adherence to their medication regimens. Experimental research supports the contention that the stress associated with being stigmatized for one's race may reduce the behavioral self-regulation necessary to maintain positive health behaviors such as medication adherence (47) . The stress and depression of discrimination can further hinder positive affect and motivation and deplete the coping resources necessary to engage in consistent medication-taking behaviors (48) .
To date, research examining the relationship between perceived discrimination and medication adherence has focused on relatively small samples of HIV-positive patients and has not examined the mechanisms underlying this relationship. The association of perceived discrimination and medication adherence among hypertensive patients remains untested. Therefore, in this study, we examined the relationship between perceived discrimination and medication adherence among hypertensive black patients, and the role of stress and depressive symptoms in this relationship (see Fig. 1 ). We hypothesized that a) perceived discrimination at baseline would be associated with medication adherence at 12 months (Pathway 1); b) perceived discrimination would be associated with stress and depression at 6 months (Pathway 2); c) stress and depression at 6 months would be associated with medication adherence at 12 months (Pathway 3); and d) stress and depression would contribute to the relationship between perceived discrimination and medication adherence (pathway 4).
METHODS

Sample and Procedure
The current study was conducted as part of a 30-site cluster-randomized controlled trial, Counseling African Americans to Control Hypertension (CAATCH) (30) . The objective of the CAATCH trial was to evaluate the effectiveness of a multilevel intervention targeting physicians and patients compared with usual care in improving blood pressure control in hypertensive black patients receiving care in 30 underserved community health centers (CHCs) in the metropolitan New York City area from 2004 to 2008. Patients were eligible if they a) self-identified as African American/black, b) were receiving care in a CHC site, c) had been diagnosed as having hypertension (International Classification of Diseases: 401-401.9), c) had uncontrolled blood pressure (Q140/90 mm Hg or Q130/80 mm Hg for patients with diabetes or kidney disease) based on mean measurements using an automated BPTru device, d) were taking at least one antihypertensive medication, e) were 18 years or older, and f) were fluent in English.
CHCs in the study were randomized to the intervention group or to usual care. The intervention consisted of computerized interactive patient education designed to increase hypertension knowledge, home blood pressure monitoring, and group behavioral counseling sessions focused on adoption of therapeutic life-style recommendations including dietary change, reducing intake of sodium, increasing physical activity, and improving adherence to antihypertensive medication regimens. Patients in the usual care condition received print publications of the National Heart, Lung and Blood Institute on lowering blood pressure and the Dietary Approaches to Stop Hypertension eating plan. Additional details of the CAATCH trial are reported elsewhere (49) . A total of 1056 patients were enrolled in the CAATCH trial. Patients completed face-to-face interviews with trained research assistants at their CHC at baseline and at 6 and 12 months. The current study includes only those 463 CAATCH trial participants who had complete data on the measures of perceived discrimination at baseline, on the measures of stress and depression at 6 months, and on the measure of medication adherence at 12 months. All participants provided informed consent, and all study procedures were approved by the institutional review board at New York University School of Medicine and at all study sites.
Measures
Perceived racial discrimination was assessed at baseline with the Schedule of Racist Events (SRE) questionnaire (50) measured during the baseline interview. The SRE is a self-report measure consisting of 18 items that assess exposure to discriminatory experiences across a variety of domains including service settings, schools, the workplace, and public places. Each item is responded to 3 times on a 6-point Likert scale to indicate frequency of perceived exposure to discrimination in the past year, over the lifetime (1 = never; 3 = sometimes; 6 = almost all of the time), and appraisal of the experience as stressful (1 = not at all; 6 = extremely). Scores are summed to yield three subscale scores: lifetime, past year, and stress, with higher scores indicating more frequent exposure to perceived discrimination (range, . Previous research has demonstrated high reliabilities (> Q .90) for each of the scales, and the scale has been correlated with a number of health outcomes (51Y53). Only the past year and lifetime scales of the SRE were used in the current study. Cronbach > reliabilities for the study sample were past year (> = .93) and lifetime (> = .94) at baseline. To provide a multidimensional but parsimonious perceived racial discrimination variable for the current study, a unit-weighted composite perceived discrimination score was created by summing z scores for the lifetime and past year scales of the SRE and calculating an average composite perceived discrimination score.
Stress was assessed at baseline and at 6 and 12 months with the Perceived Stress Scale (54), a 14-item self-report scale that measures the appraisal of life situations as stressful. Items are responded to on a 5-point Likert scale to indicate how often participants experienced stressful thoughts and feelings in (27) 132 (28) Diastolic, mm Hg 89 (13) 81 (16) 80 (16) the previous month (0 = never; 2 = sometimes; 4 = very often). Scores are summed, with higher scores indicating greater perceived stress (range, 0Y56). The Perceived Stress Scale has been found to have adequate reliability in previous studies with black populations (> = .73Y.76) (53, 55) . Cronbach > reliability for the current sample was .68 at 6 months.
Depression was assessed at baseline and at 6 and 12 months with the Patient Health Questionnaire-9 (56), a nine-item measure of depressive symptoms. Initial items are responded to on a 4-point Likert scale to indicate how often participants experienced nine different symptoms of depression over the previous 2 weeks (0 = not at all; 4 = nearly every day). A final question, scored on a 4-point Likert scale, assesses to what extent the reported symptoms interfered with the participant's normal functioning. Scores are summed, with higher scores indicating increased depressive symptoms (range, 0Y36). The Patient Health Questionnaire-9 has demonstrated adequate reliability in previous research with black samples (57) . Cronbach > reliability for the current sample was .85 at 6 months.
Medication adherence was assessed at baseline and at 6 and 12 months with the Morisky Medication Adherence Measure (58), a four-item self-report measure of patient medication-taking behavior with a yes/no response format (e.g., ''Have you ever forgotten to take your blood pressure medication?''; When you feel badly due to the medicine, do you skip it?''). Yes responses are summed creating a continuous variable, with higher scores indicating greater nonadherence to prescribed hypertensive medications. The Morisky scale has demonstrated strong reliability (> = .90) in previous research with low-income urban samples (59) , and it has been highly correlated with objective measures of adherence, including pharmacy fill and blood pressure control rates (11, 48) . Cronbach > reliability of the scale for the current sample was .65 at 12 months.
Medical comorbidity was assessed using the Charlson Comorbidity Index (60), a weighted index that evaluates the longitudinal risk of mortality, taking into account the number and severity of comorbid disease. Higher scores indicate increased risk of mortality.
Demographic variables assessed included age, sex, household income, education level, marital status, employment status, and health insurance status.
Analyses
The objectives of the study were to determine whether perceived racial discrimination at baseline is associated with medication adherence at 12-month follow-up and to examine whether depression and stress measured at 6-month follow-up might partially account for this relationship. A strong causal meditational model could not be tested with these data because the critical time points to assess the lags between the variables were not known and almost certainly did not correspond to our assessments. In addition, all measures were self-reports and were not manipulated. Nonetheless, we used the Preacher and Hayes (61) mediational plat form with bootstrapping (stratified by site) confidence intervals to estimate the indirect association of perceived discrimination measured at baseline and medication adherence measured at 12 months with stress and depression measured at 6 months in the model. These analyses were done accounting for the clustering of the data among the 30 study sites. Medication adherence was the dependent variable; perceived discrimination was the independent variable; and depression and stress, measured at 6 months, were the hypothesized mediators. Bootstrapping is a nonparametric analytic method that allows for the simultaneous examination of multiple mediators without an assumption of normality. It is recommended for its high power to detect associations while reducing Type I error in relatively small samples. The method consists of repeatedly sampling from the data set 5000 times and estimating the indirect association for each resampled data set. This process creates an empirical approximation of the product of the coefficients for Path a and Path b, which is used to construct confidence intervals for the indirect association (61) .
An unadjusted mediation model was tested first, followed by an adjusted model controlling for covariates. Potential covariates were selected based on variables that have been shown to influence medication adherence in previous research (age, sex, marital status, education, income, and comorbidity). Preliminary univariate regressions were conducted to examine the influence of each of the proposed covariates as well as the intervention on medication adherence. Only age (A = j.206, p G .001) and the intervention (A = j.116, p = .007) were significantly associated with medication adherence. Age was treated as a covariate in the adjusted model. Although the intervention was related to medication adherence, it did not meet the homogeneity of regression assumption necessary to include it as a covariate. Thus, we elected to do a sensitivity analysis with and without controlling for intervention in the model. We found that the results were not different for the two models; thus, we report the results without controlling for the intervention.
RESULTS
The sample consisted of 463 patients from 31 community health clinics with a mean (standard deviation) age of 57.9 (11.8) years. As shown in Table 1 , 74% were female, 71% had an income of $20,000 or less, 67% had a high school education or less, 66% were unemployed, and 53% were on Medicaid. At baseline, the mean blood pressure for the sample was 150/89 mm Hg, and the mean number of hypertensive medications per patient was 1.88. A multivariate analysis of variance conducted on the original sample of 1056 participants, for whom we had adequate data on all variables, revealed no significant differences in education, income, age, perceived discrimination, or baseline measures of systolic and diastolic blood pressure, stress, depression, or medication adherence between the participants used for the current analysis and the remainder of the study sample.
The results of the mediation analyses suggest that taken together, stress and depression may account for the relationship between perceived racial discrimination and medication adherence. The results of both the unadjusted and adjusted model were essentially the same. We report only the results for the unadjusted model. All model parameters in the mediation pathways are reported as unstandardized regression coefficients. In the first pathway in the model, the total association of perceived discrimination at baseline and medication adherence at 12 months was statistically significant (B = 0.138, p = .011). In the second pathway, the association of perceived discrimination at baseline and both depression (Pathway 2a: B = 1.47, p = .001) and stress (Pathway 2b: B = 2.24, p = .001) at 6 months was also statistically significant. In the third pathway, the association of depression at 6 months and medication adherence at 12 months was statistically significant (Pathway 3a: B = 0.0435, p G .001), whereas the association of stress was not independently significant by conventional levels of statistical significance (Pathway 3b: B = 0.0130, p = .065). When both stress and depression were included in the model, there was a 65% reduction in the total direct effect of perceived discrimination on medication adherence, and the relationship was no longer significant (Pathway 4: B = 0.049, p = .35; see Fig. 2 ).
Although the specific indirect association of stress to medication adherence is not independently significant with depression in the model, we also evaluated the partial relation between stress and adherence in the absence of depression. In this analysis, stress was significantly related to adherence (B = 0.025, p = .001). This finding and the nonzero (albeit not conventionally significant) parameter estimate for stress with depression in the model suggest that although stress is not a significant independent contributor to poor medication adherence above and beyond depression, it nonetheless contributes to the variance in medication adherence.
DISCUSSION
This study examined the relationship between perceived discrimination at baseline and medication adherence at 12 months, and the role that stress and depression at 6 months may play in this relationship among hypertensive black patients enrolled in the CAATCH trial. Our results suggest that there was a direct relationship between perceived discrimination at baseline and medication adherence at 12 months but that the association of stress and depression with discrimination may contribute to this relationship. Our findings are consistent with existing research on the relationship of perceived discrimination, stress, and depression to medication adherence among other populations with chronic diseases. For example, a longitudinal study of a multiracial sample of 57 people living with HIV or AIDS found that past year and lifetime exposure to racial perceived discrimination and the distress associated with perceived discrimination were significant predictors of poor adherence, but sexual orientation and HIV-related perceived discrimination were not (42) . Similar results were found in a study of 152 black HIV-positive men, in which greater exposure to perceived racial discrimination but not perceived discrimination based on HIV status or sexual orientation was associated with poor adherence for 6 months (44). Another cross-sectional study found that perceived racial discrimination from health care providers was not associated with medication adherence in a multiracial HIV-positive sample, although perceived socioeconomic statusYbased treatment discrimination was (43) .
Although this is the first study to date to quantitatively examine the role of stress and depression in the relationship between perceived discrimination and medication adherence in a hypertensive population, our results are consistent with qualitative studies of black hypertensive populations. Previous research has found that black patients tend to view hypertension as a stress-related illness that can be controlled through stress reduction and that this belief is associated with lower medication adherence (20) . A number of qualitative studies have found that for black people with hypertension, perceived discrimination and stress may be unique barriers that impede adherence by interfering with patients' ability to maintain a consistent medication regimen. For example, a predominantly low-income sample of black people with hypertension reported that perceived discrimination by physicians, neighborhood violence, and limited financial resources were all factors that influenced patients to mistrust their physicians' recommendations regarding medication, to prioritize immediate physical safety over medication management, and to experience stress over decisions regarding allocation of severely limited resources to daily needs or expensive medications (8) . In a study of rural, predominantly low-income black hypertensive participants residing in the southern United States, participants believed that the stress associated with dealing with prejudice in a variety of settings and managing the multiple tasks and obligations of daily life without adequate resources was related to difficulties effectively managing the disease (7). These studies suggest that, in addition to impeding the maintenance of optimal adherence behaviors, the stress associated with even vicariously experienced racial perceived discrimination may heighten feelings of racial mistrust, increase patients' perceptions that their physicians are biased, and limit their willingness to accept recommendations regarding medication. In addition, a number of quantitative studies have demonstrated, using longitudinal models, a significant relationship between acute and chronic stress (32) , social-and health-related stress (31) , and incident stressful and traumatic events (33) and poor adherence to antiretroviral medication among multiracial samples.
Our results regarding the role of depression in the relationship between perceived discrimination and medication adherence are consistent with research on perceived discrimination and depression and research on depression and medication adherence. The relationship between perceived discrimination and mental health outcomes, such as depression, is among the most consistent results found in research on the health impact of perceived discrimination (36,37,62Y64) . A meta-analysis of 12 studies found that depression is consistently associated with poor medication adherence across a number of samples with a variety of chronic diseases (21) , and similar results have been found in black hypertensive samples (22, 26) . One potential explanation for the association between depression and medication adherence that has received support in the empirical literature is that depression reduces patients' self-efficacy to maintain their medication regimen. At least two recent studies have found a significant association between self-efficacy and medication adherence among African American people with hypertension (65, 66) , and self-efficacy mediated the depressionYmedication adherence relationship in this population (26) .
In our study, although stress contributed to the overall model, it did not contribute independently of depression to the perceived discriminationYmedication adherence relationship. These results are consistent with research on the interplay of stress and depression in adherence to antiretroviral medication among HIV-positive patients of color. In a prospective study of patients undergoing PERCEIVED DISCRIMINATION AND MEDICATION ADHERENCE Psychosomatic Medicine 76:229Y236 (2014)treatment of HIV infection, Bottonari and colleagues (32) found that patients differed in the extent to which stress influenced medication adherence. Their results suggest that increased periods of acute or chronic stress may be associated with lapses in medication adherence primarily for those who struggle with depression.
Although promising, our results should be interpreted with caution in light of certain limitations. Our results may have been influenced by measurement error. All data used in the current study were based on self-report measures collected in face-to-face interviews and are therefore subject to recall bias and social desirability, as well as the influence of patient personality traits, which were not measured. Although self-report measures of medication adherence can potentially result in an overestimation of adherence, the Morisky Medication Adherence Measure has been found to correlate significantly with objective measures of adherence such as pharmacy fill data and blood pressure control (11, 48) , thereby providing evidence of its validity. Nonetheless, future research would benefit from the use of objective measures of medication adherence.
Our sample represents only those participants who had complete data on the measures under examination in the current study, and although no differences were found between participants with complete data and those with incomplete data on demographics or on the primary variables examined in the study at baseline, it is nonetheless possible that our results are limited by selection bias driven by participant characteristics we were unable to account for in our analyses. For example, study participants who had complete data on all of the variables may have differed in cognitive function, memory, or external locus of control, all of which have been associated with medication adherence in previous studies (67) . Furthermore, the participants in our sample were willing to participate in a clinical trial in which they were exposed to an intervention or usual care practices that sought to improve medication adherence, among other health behaviors, and may not be representative of other black hypertensive patients. That our sample is not representative also restricts the ability to generalize our results beyond urban low-income black hypertensive outpatients. To draw more definitive conclusions about the relationship between perceived discrimination and medication adherence among black people with hypertension more generally, additional research with more representative samples is warranted. Nonetheless, research suggests that black patients who are unwilling to participate in research may harbor greater feelings of distrust regarding medical research than those who choose to participate (68) . Therefore, it is likely that our results underestimate, rather than overstate, the influence of perceived discrimination on medication adherence.
All data in our study were collected through face-to-face interviews conducted by racially diverse research assistants. Research suggests that participants are likely to underreport sensitive experiences, such as those with perceived discrimination, in cross-racial dyads (69) . It is possible that cross-racial interview dyads influenced participants to underreport their experiences with perceived discrimination, thereby underestimating the impact of perceived discrimination on medication adherence.
Finally, although our analysis includes variables assessed across three time points using a mediation model, which suggests a possible directional association, it does not assess the change in medication adherence, perceived discrimination, stress, or depression over time. Therefore, it is not a true test of mediation, and definitive conclusions regarding the directionality and causality of the observed relationships cannot be drawn. Indeed, we suspect that the experience of discrimination and its impact on depression and stress may have occurred long before this study took place. However, these results certainly suggest that future studies, perhaps with experimental manipulations to heighten awareness of discrimination in participants, are warranted.
Despite these limitations, our findings suggest that perceived discrimination is a psychosocial stressor that may be associated with medication adherence among black hypertensive patients and that increased stress and depression may play a role in this relationship. Furthermore, our results suggest that stress is not associated independently with poor medication above and beyond depression. Rather, perceived discrimination may only contribute to poor medication adherence via depressive symptoms, potentially among those who have difficulty coping effectively with stress. Research has shown that active coping strategies are associated with less severe psychological and physiological stress responses to perceived discrimination (70Y72), and active coping strategies have also been associated with improved adoption of positive health behaviors among patients with cancer (73) . The identification of adaptive strategies for coping with perceived discrimination, stress, and depression could lead to the development of interventions to improve mediation adherence among black hypertensive patients. Future research should consider how affect, motivation, cognitive functioning, and individual differences, such as styles of coping with perceived discrimination, may contribute to the relationship between perceived discrimination, stress, depression, and medication adherence.
